Staphylococcal epidemiology in Antarctica

One year in Antarctica: mucosal immunity at three Australian stations

The effect of a year's isolation in Antarctica on the human mucosal immune system was assessed during the winter of 1992 at three Australian Antarctic stations: Casey, Davis and Mawson. Saliva samples were collected from each expeditioner prior to their departure from Australia and during each month in Antarctica. The concentrations of salivary immunoglobulins IgA and IgG were significantly different between the three stations, but there were no differences for salivary IgM and albumin. The mean concentrations of IgA were higher at Mawson (P < 0.008), and the mean concentrations of IgG were lower at Davis (P < 0.001) compared with the other stations. Ranges of values observed at the stations over the 12-13 months were similar. The variability of values within individuals showed station differences for salivary IgM and IgG only. The study revealed significant changes in salivary immunoglobulin values over the period in Antarctica, with similar patterns at the three Australian stations. The salivary IgA and IgM levels were lower in the first 4 months in Antarctica (January-April) and increased to maximum values in July-August, before returning to mean levels when isolation was broken in October-November. The patterns of salivary IgA and IgM suggest that stressors due to isolation may play a role in alterations of mucosal immunity in expeditioners in Antarctica.

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage

BACKGROUND

Nosocomial infections cause significant patient morbidity and mortality. The 2.5 million nosocomial infections that occur each year cost the US healthcare system $5 million to $10 million. Staphylococcus aureus has long been recognized as an important pathogen in human disease and is the most common cause of nosocomial infections.

OBJECTIVE

To describe the epidemiology of S. aureus nosocomial infections that are attributable to patients' endogenous colonization.

DATA SOURCES

Review of the English-language literature and a MEDLINE search (as of September 1997).

DATA SYNTHESIS

The ecologic niche of S. aureus is the anterior nares. The prevalence of S. aureus nasal carriage is approximately 20-25%, but varies among different populations, and is influenced by age, underlying illness, race, certain behaviors, and the environment in which the person lives or works. The link between S. aureus nasal carriage and development of subsequent S. aureus infections has been established in patients on hemodialysis, on continuous ambulatory peritoneal dialysis, and those undergoing surgery. S. aureus nasal carriers have a two-to tenfold increased risk of developing S. aureus surgical site or intravenous catheter infections. Thirty percent of 100% of S. aureus infections are due to endogenous flora and infecting strains were genetically identical to nasal strains. Three treatment strategies may eliminate nasal carriage: locally applied antibiotics or disinfectants, systemic antibiotics, and bacterial interference. Among these strategies, locally applied or systemic antibiotics are most commonly used. Nasal ointments or sprays and oral antibiotics have variable efficacy and their use frequently results in antimicrobial resistance among S. aureus strains. Of the commonly used agents, mupirocin (pseudomonic acid) ointment has been shown to be 97% effective in reducing S. aureus nasal carriage. However, resistance occurs when the ointment has been applied for a prolonged period over large surface areas.

CONCLUSIONS

Given the importance of S. aureus nosocomial infections and the increased risk of S. aureus nasal carriage in patients with nosocomial infections, investigators need to study cost-effective strategies to prevent certain types of nosocomial infections or nosocomial infections that occur in specific settings. One potential strategy is to decrease S. aureus nasal carriage among certain patient populations.

Temporal study of staphylococcal species on the skin of human subjects in isolation and clonal analysis of Staphylococcus capitis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis

The staphylococcal skin floras of an isolated group of subjects were studied for 1 year. A wide variation in isolation patterns was found for different species. Staphylococcus intermedius, previously thought to be of veterinary origin, was found to be part of the resident flora of some subjects, and this may indicate a wider role for it in clinical infection. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of S. capitis isolates indicated persistent skin colonization at some sites; each region was colonized by only one clone of that species, although an adjacent area could be inhabited by a separate clone. Nine clonal groups were identified by SDS-PAGE; there was a degree of specialization between the groups with regard to the sites which they colonized. The interaction between species at a single site was less well defined. Noncolonizing isolates often exhibited phenotypic similarities that were lower than expected when compared with their presumed source. The results of SDS-PAGE analysis were compared with immunoblotting, antibiograms, and biotyping, and SDS-PAGE analysis was found to be a useful and practical tool for epidemiological work.

A long-term study of the nasal carriage of Staphylococcus aureus in healthy Nigerian students

892 nasal swabs were collected from 50 pharmacy students (25 male and 25 female) over a period of 15 months. 323 (36.2%) contained Staphylococcus aureus and analysis of the results showed that 19 (38%) of the subjects were true nasal carriers of S. aureus, 23 (46%) were non-carriers, and the other 8 (16%) were sporadic non-carriers. 84% of the 162 isolates tested were resistant to penicillin and 58% were resistant to tetracycline.

Staphylococcus aureus in Antarctica: carriage and attempted eradication

The carriage of Staphylococcus aureus was studied in a group of 28 men living in a totally isolated environment for a year. Initially, nasal, axillary and perineal swabs were taken at weekly intervals, but from week 24 throat swabs were taken from known nasal carriers. Several attempts were made during the study to eradicate S. aureus. Eight subjects consistently carried their own phage type throughout the study, despite the application of antibacterial agents. In three subjects strains were isolated late in the study of a phage type which had either not been isolated before in this study, or had not been found for a prolonged period. Nine of the 12 nasal carriers also yielded S. aureus from the throat. It is apparent that following attempted eradication, S. aureus may seem to disappear, only to reappear some time later; 'eradication' in this case would be an erroneous appellation.

Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus

Staphylococcus aureus is a ubiquitous organism that is normally carried on the skin and body surfaces of man. The nares are sites frequently colonized, and patients and hospital personnel represent the major source of infection. The occurrence of staphylococcal infection depends on the availability of staphylococci and the host resistance to infection. Factors that influence the carrier rate of S. aureus include minimal colonizing dose, effects of antimicrobial therapy, disinfectants in the environment, coincidental respiratory infections, possible effect of immune factors, duration of hospital stay, and regular needle injections. Certain patients such as drug abusers, patients with diabetes, and patients with chronic renal failure are at high risk of S. aureus infections. although underlying immune deficiencies are present, increased carrier rate also might be related to regular needle use, as shown among allergy patients. The significance of carrier state has been defined in outbreaks in hospital nurseries, postoperative patients, and systemic infections such as endocarditis in the drug abuser, the toxic shock syndrome, and dermatologic infections.

Antimicrobial sensitivity patterns of hospital and non-hospital strains of Staphylococcus aureus isolated from nasal carriers

The nasal carriage rate of Staphylococcus aureus was significantly higher in hospitalized persons (children, adult females and staff) - 53.8%, - than in similar persons at a local clinic - 29.8% (P less than 0.001) - in Ile-Ife, Nigeria. However, unlike studies carried out elsewhere, a higher proportion of S. aureus strains obtained from persons at the clinic were resistant to commonly used antimicrobial agents than were strains isolated in the hospital. This has been attributed to the ease at which these drugs can be obtained by the general population and used unsupervised and indiscriminately. Methicillin was the most effective antimicrobial agent against pathologic staphylococci (2.2% resistance), followed by erythromycin (16.5% resistance), co-trimaxozole (28.0% resistance), chloramphenicol (76.9% resistance), tetracycline (78.6% resistance) and penicillin and ampicillin (97.8% resistance). The widespread resistance of S. aureus to penicillin and ampicillin (and other antimicrobial agents) is of clinical significance in the treatment of post-operative infections, since carriers are reportedly more prone to such infections than are non-carriers.

Nasal carriers of coagulase-positive staphylococci in a Nigerian hospital community

Nasal swabs taken from 324 subjects in a Nigerian hospital were examined for the presence of coagulase positive staphylococci. The subjects used in this study included the patients, staff and "auxiliaries" aged from one day to 70 years. The results obtained show that approximately 50% of all the subjects were nasal carriers of Staphylococcus aureus and that age, occupation and length of the subjects' stay in hospital had a significant effect on this figure. It was also found that there is no significant difference between the prevalence of nasal carriage of S. aureus amongst the hospital staff and the patients.